Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus

A. Zelniker, Thomas; P. Bonaca, Marc; H.M. Furtado, Remo; Mosenzon, Ofri; Kuder, Julia; A. Murphy, Sabina; L. Bhatt, Deepak; A. Leiter, Lawrence; K. McGuire, Darren; Wilding, John; Budaj, Andrzej; Gábor Kiss, Róbert; Padilla, Francisco; Gause‐Nilsson, Ingrid; Maria Langkilde, Anna; Raz, Itamar; S. Sabatine, Marc; D. Wiviott, Stephen

doi:10.1161/circulationaha.119.044183

Public

Effect of Dapagliflozin on Atrial Fibrillation in Patients With Type 2 Diabetes Mellitus

Published in Circulation • Jan 27, 2020

Authors:

Thomas A. Zelniker

Marc P. Bonaca

Remo H.M. Furtado

Abstract

Background: Atrial fibrillation (AF) and atrial flutter (AFL) are associated with both diabetes mellitus and its related comorbidities, including hypertension, obesity, and heart failure (HF). SGLT2 (sodium-glucose cotransporter 2) inhibitors have been shown to lower blood pressure, reduce weight, h...

Subject

Dapagliflozin

Medicine

Atrial fibrillation

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!